Document:

Exhibit 10.1

 

FORM OF SHARE
EXCHANGE AGREEMENT

  

SHARE EXCHANGE
AGREEMENT

 

Dated February
25, 2014

 

by and among

 

Osler Incorporated,

a Nevada corporation

 

C. Leo Smith,

an individual

 

America Greener
Technologies Corporation, 

an Arizona
corporation

 

and

 

the Shareholders
of America Greener

Technologies
Corporation

    	 

    	 

    

SHARE EXCHANGE
AGREEMENT

 

               This
Share Exchange Agreement (“Agreement”) dated February 25, 2014, is between and among Osler Incorporated
(“Osler”), a corporation organized under the laws of the State of Nevada, having an office for the transaction
of business at 900 SE Third Avenue, Suite 202, Fort Lauderdale, FL 33316, C. Leo Smith, an individual having an office for the
transaction of business at 900 SE Third Avenue, Suite 202, Fort Lauderdale, FL 33316 (“Smith”), America
Greener Technologies Corporation (“AGT”), a corporation organized under the laws of the State of Arizona,
having an office for the transaction of business at 254 South Mulberry Street, Suite 113, Meza, AZ 85202, and the shareholders
of AGT listed on the signature page and Schedule A hereto, constituting all of the shareholders of AGT (collectively, the
“AGT Shareholders” and individually an “AGT Shareholder”), each having an
address set forth on the signature pages hereto.

 

W I T N E
S S E T H

 

               WHEREAS,
Osler is a public “shell” company which is quoted in the over the counter markets on the OTCQB Tier of the OTC Markets
under the symbol “OSLE.”

 

               WHEREAS,
Smith is the sole officer and director of Osler.

 

               WHEREAS,
Insurance Marketing Solutions, LLC (“IMS”), an entity of which Smith is the sole member, is the record
and beneficial owner of 1,822,601 shares of common stock of Osler (the “Osler Common Stock”), representing
approximately 73% of the outstanding shares of Osler Common Stock (the “Control Shares”).

 

               WHEREAS,
the AGT Shareholders own all of the issued and outstanding shares of the common stock of AGT (the “AGT Common Stock”).

 

               WHEREAS,
the Parties desire that Osler acquire all of the AGT Common Stock from the AGT Shareholders solely in exchange for an aggregate
of 15,000,000 shares (the “Exchange Shares”) of newly issued shares of Osler Common Stock pursuant to
the terms and conditions set forth in this Agreement.

 

               WHEREAS,
immediately following the Closing (as hereinafter defined), AGT will designate officers and directors of Osler, Smith will resign
all positions with Osler, AGT will become a wholly-owned subsidiary of Osler and the Exchange Shares will represent approximately
86% percent of the total outstanding shares of Osler Common Stock.

 

               NOW
THEREFORE, on the stated premises and for and in consideration of the foregoing recitals which are hereby incorporated by
reference, the mutual covenants and agreements hereinafter set forth and the mutual benefits to the parties to be derived herefrom
and for other good and valuable consideration, the sufficiency and receipt of which are hereby acknowledged, the Parties hereto
agree as follows:

 

SECTION 1

SHARE EXCHANGE

 

               1.1          The
Exchange. At the Closing, the shares of AGT Common Stock issued and outstanding immediately prior to the Closing Date
shall be exchanged for the Exchange Shares in the amounts set forth on Schedule A attached hereto.

    	2

    	 

    

               1.2.         Closing.
The closing (“Closing”) of the Transaction shall occur within five (5) business days following the satisfaction
or waiver of all conditions precedent to Closing set forth in Section 7 hereof (the “Closing Date”).

 

               1.3.         Closing
Events. At the Closing, each of the respective parties hereto shall execute, acknowledge, and deliver (or shall cause
to be executed, acknowledged, and delivered) any and all stock certificates, officers’ certificates, financial statements,
schedules, agreements, resolutions, rulings, or other instruments required by this Agreement to be so delivered at or prior to
the Closing, and the documents and certificates provided in Section 7, together with such other items as may be reasonably requested
by the parties hereto and their respective legal counsel in order to effectuate or evidence the transactions contemplated hereby.
If agreed to by the parties, the Closing may take place through the exchange of documents (other than the exchange of stock certificates)
by efax, fax, email and/or express courier. At the Closing, the ownership of the shares of AGT Common Stock set forth on Schedule
A hereto currently held by the AGT Shareholders on an un-certificated basis shall be transferred to Osler without any further
action by the AGT Shareholders, and the Exchange Shares shall be issued in the names and denominations set forth on Schedule A
hereto.

 

               1.5.         Standstill.

 

                              (a)            Until
the earlier of the Closing or the Outside Date (as hereinafter defined) (the “No Shop Period”), neither
AGT nor any AGT Shareholder will (i) solicit or encourage any offer or enter into any agreement or other understanding, whether
written or oral, for the sale, transfer or other disposition of any capital stock or assets of AGT to or with any other entity
or person, except as contemplated by the Transaction, other than sales of goods and services by AGT in the ordinary course of
its business; (ii) entertain or pursue any unsolicited communication, offer or proposal for any such sale, transfer or other disposition;
or (iii) furnish to any person or entity (other than Osler, and its authorized agents and representatives) any nonpublic information
concerning AGT or its business, financial affairs or prospects for the purpose or with the intent of permitting such person or
entity to evaluate a possible acquisition of any capital stock or assets of AGT. If either AGT or any of the AGT Shareholders
shall receive any unsolicited communication or offer, AGT or the AGT Shareholders, as applicable, shall immediately notify Osler
of the receipt of such communication or offer.

 

                              (b)            During
the No-Shop Period, Osler will not (i) solicit or encourage any offer or enter into any agreement or other understanding, whether
written or oral, for the sale, transfer or other disposition of any capital stock or assets of Osler to or with any other entity
or person, except as contemplated herein, other than sales of goods and services by Osler in the ordinary course of its business;
(ii) entertain or pursue any unsolicited communication, offer or proposal for any such sale, transfer or other disposition; or
(iii) furnish to any person or entity (other than AGT, and its authorized agents and representatives) any nonpublic information
concerning Osler or its business, financial affairs or prospects for the purpose or with the intent of permitting such person
or entity to evaluate a possible acquisition of any capital stock or assets of Osler. If either Osler or Smith shall receive any
unsolicited communication or offer, Osler or Smith, as applicable, shall immediately notify AGT of the receipt of such communication
or offer.

 

SECTION 2

REPRESENTATIONS,
COVENANTS, AND WARRANTIES OF AGT

 

               AGT
hereby represents and warrants to Osler and the AGT Shareholders as follows:

    	3

    	 

    

               2.1          Organization
and Good Standing. AGT is a corporation duly organized, validly existing and in good standing under the laws of the State
of Arizona, and is entitled to own or lease its properties and to carry on its business as and in the places where such properties
are now owned, leased or operated and such business is now conducted. AGT is qualified to do business as a foreign corporation
in each jurisdiction, if any, in which its property or business requires such qualification. AGT does not have any subsidiaries
and does not own, beneficially or of record, any shares or other equity interests of any other corporation or entity.

 

               2.2          Authorization;
Enforceability; No Breach. AGT has all necessary corporate power and authority to execute this Agreement and perform its
obligations hereunder. This Agreement constitutes the valid and binding obligation of AGT enforceable against it in accordance
with its terms, except as may be limited by bankruptcy, moratorium, insolvency or other similar laws generally affecting the enforcement
of creditors’ rights. The execution, delivery and performance of this Agreement by AGT and the consummation of the transactions
contemplated hereby will not:

 

                              (a)            violate
any provision of the AGT’s Articles of Incorporation or its Bylaws;

 

                              (b)            violate,
conflict with or result in the breach of any of the terms of, result in a material modification of, otherwise give any other contracting
party the right to terminate, or constitute (or with notice or lapse of time or both constitute) a default under, any contract
or other agreement to which AGT is a party or by or to which it or any of its assets or properties may be bound or subject;

 

                              (c)            violate
any order, judgment, injunction, award or decree of any court, arbitrator or governmental or regulatory body against, or binding
upon, AGT or upon the properties or business of AGT; or

 

                              (d)            violate
any statute, law or regulation of any jurisdiction applicable to the transactions contemplated herein which could have a material
adverse effect on the business or operations of AGT.

 

               2.3          Compliance
with Laws. AGT has complied with all federal, state, county and local laws, ordinances, regulations, inspections, orders,
judgments, injunctions, awards or decrees applicable to it or its business which, if not complied with, would materially and adversely
affect the business or financial condition of AGT taken as a whole.

 

               2.4          Litigation.
There is no action, suit or proceeding pending or threatened, or any investigation, at law or in equity, before any arbitrator,
court or other governmental authority, pending or threatened, nor any judgment, decree, injunction, award or order outstanding,
against or in any manner involving AGT or its properties or rights which (a) could reasonably be expected to have a material adverse
effect on AGT taken as a whole, or (b) could reasonably be expected to materially and adversely affect consummation of any of
the transactions contemplated by this Agreement.

 

               2.5          Brokers
or Finders. No broker’s or finder’s fee will be payable by AGT in connection with the Transaction, nor will
any such fee be incurred as a result of any actions by AGT.

 

               2.6          Assets.
AGT owns all rights, title and interest in and to its assets, free and clear of all liens, pledges, mortgages, security interests,
conditional sales contracts or any other encumbrances.

 

               2.8          Capitalization.
The authorized capital stock of AGT consists of 15,000,000 shares of common stock of which 8,000,000 shares are presently issued
and outstanding. Such shares of common stock are owned of record and beneficially by the AGT Shareholders and in the amounts reflected
in Schedule A. AGT has not granted, issued or agreed to grant, issue or make available any warrants, options, subscription rights
or any other commitments of any character relating to the unissued shares of capital stock of AGT. All of the shares of AGT Common
Stock are duly authorized and validly issued, fully paid and non-assessable.

    	4

    	 

    

               2.9          Full
Disclosure. No representation or warranty by AGT in this Agreement or in any document or schedule to be delivered by it
pursuant hereto, and no written statement, certificate or instrument furnished or to be furnished to Osler pursuant hereto or
in connection with the negotiation, execution or performance of this Agreement contains, or will contain, any untrue statement
of a material fact or omits, or will omit, to state any fact necessary to make any statement herein or therein not materially
misleading or necessary to a complete and correct presentation of all material aspects of the businesses of AGT.

 

               2.10        Actions
and Proceedings. There is no outstanding order, judgment, injunction, award or decree of any court, governmental or regulatory
body or arbitration tribunal against or involving AGT. There is no action, suit or claim or legal, administrative or arbitral
proceeding or (whether or not the defense thereof or liabilities in respect thereof are covered by insurance) pending or threatened
against or involving AGT or any of its properties or assets. There is no fact, event or circumstances that may give rise to any
suit, action, claim, investigation or proceeding.

 

               2.11        State
Takeover Statutes. No “fair price,” “moratorium,” “control share acquisition” or other
similar antitakeover statue or regulation enacted under state or federal laws in the United States, with the exception of Article
2, Chapter 23 of the Arizona Revised Statutes, applicable to AGT is applicable to the transactions contemplated by this Agreement.
The action of the Board of Directors of AGT in approving the Transaction, this Agreement and the transactions contemplated hereby
is sufficient to render the restrictions on “business combinations” set forth in Article 2, Chapter 23 of the Arizona
Revised Statutes inapplicable to the Transaction, this Agreement and the other transactions contemplated hereby.

 

               2.12        Absence
of Certain Changes or Events. Except as set forth in the schedules to this Agreement:

 

                              (a)            except
in the normal course of business, there has not been (i) any material adverse change in the business, operations, properties,
assets, or condition of AGT; or (ii) any damage, destruction, or loss to AGT (whether or not covered by insurance) materially
and adversely affecting the business, operations, properties, assets, or condition of AGT;

 

                              (b)            AGT
has not (i) borrowed or agreed to borrow any funds or incurred, or become subject to, any material obligation or liability (absolute
or contingent) not otherwise in the ordinary course of business, and except for capital raised by issuance of debt or equity in
a private placement or other capital raising transaction deemed advisable by AGT; (ii) paid any material obligation or liability
not otherwise in the ordinary course of business (absolute or contingent) other than current liabilities reflected in or shown
on the most recent AGT balance sheet, and current liabilities incurred since that date in the ordinary course of business; (iii)
sold or transferred, or agreed to sell or transfer, any of its assets, properties, or rights not otherwise in the ordinary course
of business; (iv) made or permitted any amendment or termination of any contract, agreement, or license to which they are a party
not otherwise in the ordinary course of business if such amendment or termination is material, considering the business of AGT;
or (v) issued, delivered, or agreed to issue or deliver any stock, bonds or other corporate securities including debentures (whether
authorized and unissued or held as treasury stock).

    	5

    	 

    

               2.13        Continuity
of Business Enterprises. AGT has no commitment or present intention to liquidate AGT or sell or otherwise dispose of a
material portion of its business or assets following the consummation of the transactions contemplated hereby.

 

SECTION 3

REPRESENTATIONS,
COVENANTS, AND WARRANTIES

OF OSLER AND
SMITH

 

               Each
of Osler and Smith jointly and severally represent and warrant to AGT and the AGT Shareholders as follows:

 

               3.1          Organization
and Good Standing. Osler is a corporation duly organized, validly existing and in good standing under the laws of the
State of Nevada, and is entitled to own or lease its properties and to carry on its business as and in the places where such properties
are now owned, leased or operated and such business is now conducted. Osler is qualified to do business as a foreign corporation
in each jurisdiction, if any, in which its property or business requires such qualification. Osler does not have any subsidiaries.

 

               3.2          Authorization;
Enforceability; No Breach. Osler has all necessary corporate power and authority to execute this Agreement and perform
its obligations hereunder. This Agreement constitutes the valid and binding obligation of Osler enforceable against Osler in accordance
with its terms, except as may be limited by bankruptcy, moratorium, insolvency or other similar laws generally affecting the enforcement
of creditors’ rights. The execution, delivery and performance of this Agreement by Osler and the consummation of the transactions
contemplated hereby will not:

 

                              (a)            violate
any provision of the Articles of Incorporation or By-Laws of Osler;

 

                              (b)            violate,
conflict with or result in the breach of any of the terms of, result in a material modification of, otherwise give any other contracting
party the right to terminate, or constitute (or with notice or lapse of time or both constitute) a default under, any contract
or other agreement to which Osler is a party or by or to which it or any of its assets or properties may be bound or subject;

 

                              (c)            violate
any order, judgment, injunction, award or decree of any court, arbitrator or governmental or regulatory body against, or binding
upon, Osler, or upon the properties or business of Osler; or

 

                              (d)            violate
any statute, law or regulation of any jurisdiction applicable to the transactions contemplated herein which could have a material
adverse effect on the business or operations of Osler.

 

               3.3          Compliance
with Laws. Osler has complied with all federal, state, county and local laws, ordinances, regulations, inspections, orders,
judgments, injunctions, awards or decrees applicable to it or its business which, if not complied with, would materially and adversely
affect the business or financial condition of Osler.

 

               3.4          Litigation.
There is no action, suit or proceeding pending or threatened, or any investigation, at law or in equity, before any arbitrator,
court or other governmental authority, pending or threatened, nor any judgment, decree, injunction, award or order outstanding,
against or in any manner involving Osler or any of Osler’s properties or rights which (a) could reasonably be expected to
have a material adverse effect on Osler taken as a whole, or (b) could reasonably be expected to materially and adversely affect
consummation of any of the transactions contemplated by this Agreement.

    	6

    	 

    

               3.5          Brokers
or Finders. No broker’s or finder’s fee will be payable by Osler in connection with the transaction contemplated
by this Agreement, nor will any such fee be incurred as a result of any actions by Osler or Smith.

 

               3.6          The
Osler Shares. The Exchange Shares to be issued to the AGT Shareholders have been, or on or prior to the Closing will have
been, duly authorized by all necessary corporate and stockholder actions and, when so issued in accordance with the terms of this
Agreement, will be validly issued, fully paid and non-assessable and will not be issued in violation of the pre-emptive or similar
rights of any person.

 

               3.7          SEC
Reports and Financial Statements.

 

                              (a)            Osler
has filed or furnished all forms, documents and reports required to be filed or furnished by it (the “Osler SEC Documents”)
with the Securities and Exchange Commission (the “SEC”). As of their respective dates or, if amended,
as of the date of such amendment, the Osler SEC Documents complied in all material respects with the requirements of the Securities
Act, the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the Sarbanes-Oxley Act
of 2002 (the “Sarbanes-Oxley Act”), as the case may be, and the applicable rules and regulations promulgated
thereunder, and none of the Osler SEC Documents contained any untrue statement of a material fact or omitted to state any material
fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they
were made, not misleading. As of the date of this Agreement, there are no outstanding or unresolved comments in comment letters
received from the SEC or its staff. There has been no material correspondence between the SEC and Osler since January 1, 2010
that is not available on the SEC’s Electronic Data Gathering and Retrieval database.

 

                              (b)            Osler
has established and maintains disclosure controls and procedures and internal control over financial reporting (as such terms
are defined in paragraphs (e) and (f), respectively, of Rule 13a-15 under the Exchange Act) as required by Rule 13a-15(e) under
the Exchange Act. Osler’s disclosure controls and procedures are reasonably designed to ensure that all material information
required to be disclosed by Osler in the reports that it files or furnishes under the Exchange Act is recorded, processed, summarized
and reported within the time periods specified in the rules and forms of the SEC, and that all such material information is accumulated
and communicated to Osler’s management as appropriate to allow timely decisions regarding required disclosure and to make
the certifications required pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act and all such required certifications have
been made. Osler’s management has completed an assessment of the effectiveness of Osler’s internal control over financial
reporting in compliance with the requirements of Section 404 of the Sarbanes-Oxley Act for the year ended June 30, 2013, and such
assessment concluded that such controls were effective. Neither Osler nor, to the knowledge of Osler, Osler’s independent
registered public accounting firm, has identified or been made aware of “significant deficiencies” or “material
weaknesses” (as defined by the Public Company Accounting Oversight Board) in the design or operation of Osler’s internal
controls and procedures which would reasonably be expected to adversely affect Osler’s ability to record, process, summarize
and report financial data, in each case which has not been subsequently remediated.

    	7

    	 

    

                              (c)            The
audited financial statements and unaudited interim financial statements (including all related notes and schedules) of Osler included
in the Osler SEC Documents (the “Osler Financial Statements”) complied as to form in all material respects
with the rules and regulations of the SEC then in effect, fairly present in all material respects the financial position of Osler,
as at the respective dates thereof, and the results of their operations and their cash flows for the respective periods then ended
(subject, in the case of the unaudited statements, to normal recurring year-end audit adjustments that were not or are not expected
to be, individually or in the aggregate, materially adverse to Osler), and were prepared in accordance with United States generally
accepted accounting principles (“GAAP”) applied on a consistent basis during the periods involved (except
as may be indicated therein or in the notes thereto).

 

                              (d)            Osler
is not a party to, or has any commitment to become a party to, any joint venture, off-balance sheet partnership or any similar
contract (including any contract or arrangement relating to any transaction or relationship between or among Osler, on the one
hand, and any unconsolidated affiliate, including any structured finance, special purpose or limited purpose entity or person,
on the other hand, or any “off-balance-sheet arrangement” (as defined in Item 303(a) of Regulation S-K under the Exchange
Act)), where the result, purpose or intended effect of such contract is to avoid disclosure of any material transaction involving,
or material liabilities of, Osler or its affiliates.

 

                              (e)            Except
(a) as reflected or reserved against in Osler’s most recent unaudited balance sheet (or stated in the notes thereto) at
December 31, 2013 included in the Osler SEC Documents and (b) for liabilities and obligations incurred since December 31, 2013
through the date of this Agreement in the ordinary course of business consistent with past practice as set forth on Schedule
3.7(e) hereto (the “Osler Liabilities”), and Osler does not have any liabilities or obligations
of any nature, whether or not accrued, absolute, contingent or otherwise, that would be required by GAAP to be reflected on a
balance sheet of Osler (or in the notes thereto).

 

               3.8          No
Material Adverse Changes. Since the date of the Osler Financial Statements, there has been no material adverse change
in the assets, operations, financial condition or prospects of Osler, taken as a whole.

 

               3.9          Books
and Records. The financial records of Osler accurately reflect in all material respects the information relating to the
business of Osler, the location and collection of their assets, and the nature of all transactions giving rise to the obligations
or accounts receivable of Osler.

 

               3.10        Assets;
Operations. Osler has no tangible assets. Osler is inactive and currently engages in no business operations and is considered
a “shell company” as that term is defined in the Exchange Act. Schedule 3.10 sets forth all bank and similar
accounts held in the name of Osler.

 

               3.11        Contracts.
Schedule 3.11 sets forth all contracts to which Osler is a party. Other than as set forth on Schedule 3.11, Osler is not
a party to any contracts, agreements, engagement letters, or other understandings which bind Osler or its assets. Other than as
set forth on Schedule 3.11, all such contracts are immediately terminable following the Closing without any liability to Osler.

 

               3.12        Capitalization.
The authorized capital stock of Osler consists of 75,000,000 shares of common stock, of which 2,505,014 shares are presently issued
and outstanding, and 5,000,000 shares of preferred stock, of which no shares are presently issued and outstanding. As of the date
hereof, Osler has no outstanding warrants or options, and Osler has not granted, issued or agreed to grant, issue or make available
any warrants, options, subscription rights or any other commitments of any character relating to the unissued shares of capital
stock of Osler. All of the issued and outstanding capital stock of Osler has been duly authorized and validly issued, fully paid
and non-assessable, and was issued in compliance with applicable securities laws. Smith is not the beneficial owner of any shares
of Osler Common Stock (as that term is defined in the Exchange Act) other than the Control Shares.

    	8

    	 

    

               3.13        Taxes.
All required tax returns or federal, state, county, municipal, local, foreign and other taxes and assessments have been properly
prepared and filed by Osler for all years for which such returns are due unless an extension for filing any such return has been
properly prepared and filed. Any and all federal, state, county, municipal, local, foreign and other taxes, assessments, including
any and all interest, penalties and additions imposed with respect to such amounts have been paid or provided for. Osler has no
outstanding tax liabilities and has not received notice of any tax inquiry or audit against it.

 

               3.14        Full
Disclosure. No representation or warranty by Osler and/or Smith in this Agreement or in any document or schedule to be
delivered by it pursuant hereto, and no written statement, certificate or instrument furnished or to be furnished to Osler pursuant
hereto or in connection with the negotiation, execution or performance of this Agreement contains, or will contain, any untrue
statement of a material fact or omits, or will omit, to state any fact necessary to make any statement herein or therein not materially
misleading or necessary to a complete and correct presentation of all material aspects of the businesses of Osler.

 

               3.15        Actions
and Proceedings. There is no outstanding order, judgment, injunction, award or decree of any court, governmental or regulatory
body or arbitration tribunal against or involving Osler. There is no action, suit or claim or legal, administrative or arbitral
proceeding or (whether or not the defense thereof or liabilities in respect thereof are covered by insurance) pending or threatened
against or involving Osler or any of its properties or assets. There is no fact, event or circumstances that may give rise to
any suit, action, claim, investigation or proceeding.

 

               3.16        State
Takeover Statutes. No “fair price,” “moratorium,” “control share acquisition” or other
similar antitakeover statue or regulation enacted under state or federal laws in the United States, with the exception of Sections
78.378 through 78.3793 of the Nevada Revised Statutes, applicable to Osler is applicable to the transactions contemplated by this
Agreement. The action of the Board of Directors of Osler in approving the Transaction, this Agreement and the transactions contemplated
hereby is sufficient to render the restrictions on “business combinations” set forth in Sections 78.378 through 78.3793
of the Nevada Revised Statutes inapplicable to the Transaction, this Agreement and the other transactions contemplated hereby.

 

SECTION 4

REPRESENTATIONS,
COVENANTS, AND WARRANTIES

OF THE AGT
SHAREHOLDERS

 

               Each
of the AGT Shareholders hereby represents and warrants to Osler, AGT and the other AGT Shareholders as follows:

 

               4.1          Ownership
and Restrictions on shares of AGT Common Stock. The AGT Shareholder is not a party to any agreement, written or oral,
creating rights in respect to the shares of AGT Common Stock to be exchanged for the Exchange Shares pursuant to this Agreement
in any third person or relating to the voting of the shares. The AGT Shareholder is the lawful and beneficial owner of the shares
of AGT Common Stock set forth opposite such shareholders name on Schedule A hereto, free and clear of all security interests,
liens, encumbrances, equities and other charges, except for any applicable restrictions under U.S. securities laws. There are
no existing warrants, options, stock purchase agreements, redemption agreements, restrictions of any nature, calls or rights to
subscribe of any character relating to the shares of AGT Common Stock owned by such AGT Shareholder, nor are there any securities
convertible into such shares.

    	9

    	 

    

               4.2         No
Registration; Shell Status. The Exchange Shares will not be registered under the Securities Act or under applicable state
blue sky laws. Osler is a “shell company” as defined in Rule 405 of the Securities Act.

 

               4.3          Power
and Authority. The AGT Shareholder is authorized to enter into this Agreement and perform his obligations hereunder, and
no consent of any person is necessary in order for the AGT Shareholder to enter into and consummate the Transaction.

 

               4.4          Investment
Intent. The Exchange Shares are being acquired for the AGT Shareholder’s own account, for investment purposes only
and not with a view for distribution or resale to others. The AGT Shareholder will not sell or otherwise transfer the Exchange
Shares unless the Exchange Shares are subsequently registered under the Securities Act. Osler is under no obligation to register
the Exchange Shares under the Securities Act. Following the Closing, legends shall be placed on the certificates representing
the Exchange Shares to the effect that they have not been registered under the Securities Act or applicable state securities laws
and appropriate notations thereof will be made in Osler’s books and stop transfer instructions may be placed with Osler’s
transfer agent. The acquisition of the Exchange Shares represents a high risk capital investment, and the AGT Shareholder is able
to afford an investment in a speculative venture such as Osler. The AGT Shareholder has adequate means of providing for his current
financial needs and foreseeable contingencies and has no need for liquidity of its investment in the Exchange Shares for an indefinite
period of time. There is a very limited trading market for the Exchange Shares and there are no assurances a trading market will
develop in the near future, if at all; accordingly, the Exchange Shares are considered an illiquid investment. The AGT Shareholder
is an experienced and sophisticated investor, is able to fend for himself in the transactions contemplated by this Agreement,
and has such knowledge and experience in financial and business matters that it is capable of evaluating the risks and merits
of acquiring the Exchange Shares.

 

SECTION 5

COVENANTS

 

               5.1          Examinations
and Investigations. Prior to the Closing Date, the parties acknowledge that they will be entitled, through their employees
and representatives, to make such investigation and verification of the assets, properties, business and operations, books, records
and financial condition of the other, including communications with suppliers, vendors and customers, as they each may reasonably
require. No investigation by a party hereto shall, however, diminish or waiver in any way any of the representations, warranties,
covenants or agreements of the other party under this Agreement. Consummation of this Agreement shall be subject to the fulfillment
of due diligence procedures to the reasonable satisfaction of each of the parties hereto and their respective counsel.

 

               5.2          Expenses.
Each party hereto agrees to pay its own costs and expenses incurred in negotiating this Agreement and consummating the transactions
described herein. All fees and expenses associated with the Transaction, this Agreement and any transactions contemplated hereby
which are incurred or accrued by Osler prior to the Closing Date are considered by the parties hereto to be included in the Osler
Liabilities and must be satisfied prior to the Closing Date pursuant to Section 7.2(g) hereof.

 

               5.3          Further
Assurances. The parties shall execute such documents and other papers and take such further action as may be reasonably
required or desirable to carry out the provisions hereof and the transactions contemplated hereby. Each such party shall use its
best efforts to fulfill or obtain in the fulfillment of the conditions to the Closing, including, without limitation, the execution
and delivery of any documents or other papers, the execution and delivery of which are necessary or appropriate to the Closing.

    	10

    	 

    

               5.4          Confidentiality.
In the event the transactions contemplated by this Agreement are not consummated, each of the parties hereto agree to keep confidential
any information disclosed to each other in connection therewith; provided, however, such obligation shall not apply
to information which:

 

                              (a)            at
the time of disclosure was public knowledge;

 

                              (b)            after
the time of disclosure becomes public knowledge (except due to the action of the receiving party); or

  

                              (c)            the
receiving party had within its possession at the time of disclosure.

 

SECTION 6

CONDUCT OF
BUSINESS; ACCESS TO AUDITOR

 

               6.1          Conduct
of Business. From the date of this Agreement until the Closing, each of Osler and AGT shall conduct its business in the
ordinary course and consistent with prudent and past business practice, except for transactions expressly contemplated hereby,
or with the prior written consent of the other parties. Notwithstanding the foregoing, from the date of this Agreement until the
Closing, Osler will not:

 

                              (a)            create,
assume or suffer to exist any lien on any of its properties or assets, whether tangible or intangible;

 

                              (b)            sell,
assign, transfer, lease or otherwise dispose of or agree to sell, assign, transfer, lease or otherwise dispose of any its material
assets or except as otherwise provided for in this Agreement, cancel any indebtedness owed to it;

 

                              (c)            change
any method of accounting or accounting practice used by it, other than such changes required by GAAP;

 

                              (d)            issue,
grant, deliver, sell, repurchase, redeem, purchase, acquire, encumber, pledge, dispose of or otherwise transfer, directly or indirectly,
any shares of capital stock of, or other equity interests in it, or securities convertible into or exchangeable for such shares
or equity interests, or issue or grant any options, warrants, calls, subscription rights or other rights of any kind to acquire
additional shares of such capital stock, such other equity interests or such securities;

 

                              (e)            propose
or adopt any amendment or other changes to its Articles of Incorporation, its bylaws or other governing documents;

  

                              (f)             declare,
set aside or pay any dividend or distribution with respect to any share of its capital stock or declare or effectuate a stock
dividend, stock split or similar event;

 

                              (g)            issue
any note, bond, or other debt security or create, incur, assume, or guarantee any indebtedness for borrowed money or capitalized
lease obligation;

 

                              (h)            make
any equity investment in, make any loan, advance or capital contribution to, or acquire the securities or assets of any other
person;

    	11

    	 

    

                              (i)             enter
into any new or additional agreements or modify any existing agreements relating to the employment of, or compensation or benefits
payable or to become payable to, any past or present officer or director or any written agreements of any of its past or present
employees;

 

                              (j)             make
any payments out of the ordinary course of business to any of its officers, directors, employees or stockholders;

 

                              (k)            pay,
discharge, satisfy or settle any liabilities (absolute, accrued, asserted or unasserted, contingent or otherwise) other than in
the ordinary course of business, except as provided for herein;

 

                              (l)             agree
in writing or otherwise take any action that would, or would reasonably be expected to, prevent, impair or materially delay the
ability of Osler to consummate the transactions contemplated by this Agreement;

 

                              (m)           form
or acquire any subsidiaries; or

 

                              (n)            agree
or commit to take any of the actions specified in this Section 6.1.

 

               6.2          Access
to Osler Auditors. Following the execution of this Agreement by the parties, Osler shall cause its independent registered
public accounting firm to provide full access to AGT and its representatives to the work papers for the Osler audits for the fiscal
years ended June 30, 2013 and 2012 and all subsequent interim periods.

 

SECTION 7

CONDITIONS
PRECEDENT TO CLOSING

 

               7.1          Conditions
Precedent to the Obligation of Osler to Close. Osler’s obligations to effect the Transaction and consummate the
other transactions contemplated hereby are subject to the fulfillment or satisfaction, prior to or on the Closing Date, of the
following conditions; provided that these conditions are for Osler’s sole benefit and may be waived only by
Osler at any time in its sole discretion by providing AGT with prior written notice thereof:

 

                              (a)            Representations,
Warranties, Covenants and Agreements. The representations and warranties of AGT herein shall be true and correct as of
the date when made and as of the Closing Date as though made at that time (except for representations and warranties that speak
as of a specific date, which shall be true and correct as of such date), and AGT shall have performed, satisfied and complied
with the covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by them at
or prior to the Closing Date.

 

                              (b)            AGT
Board Approval. AGT’s Board of Directors shall have adopted, and not rescinded or otherwise amended or modified,
resolutions authorizing AGT to enter into this Agreement and the consummation of the transactions contemplated hereby and thereby,
including the Transaction.

 

                              (c)            No
Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted,
entered, promulgated or endorsed by any court or governmental authority of competent jurisdiction which prohibits the consummation
of any of the transactions contemplated by this Agreement.

    	12

    	 

    

                              (d)            No
Material Adverse Changes. There shall have been no adverse effect on the business, operations, properties,
prospects or financial condition of AGT that is material and adverse to AGT, taken as a whole.

 

                              (e)            Audited
Financial Statements. AGT shall have delivered to Osler audited balance sheets at December 31, 2013 and 2012 together
with audited statements of operations, cash flow and stockholders’ equity for the period from February 14, 2012 (date of
inception) through December 31, 2013, together with such unaudited interim period financial statements as shall be necessary to
satisfy the rules and regulations of the SEC (the “AGT Financial Statements”) in the opinion of AGT’s
counsel. The AGT Financial Statements shall have been prepared in accordance with GAAP applied on a consistent basis during the
periods involved (except as may be indicated therein or in the notes thereto) and the rules and regulations of the SEC and shall
be accompanied by the unqualified opinion of D’Arelli Pruzansky, P.A.

 

                              (f)             Polarchem
Agreement. AGT shall have entered into an agreement with Polarchem Associated Limited, Polarchem International Limited,
Ulf Tore Walden, David Idwal Jones, Georges Berberat and the Duitoit-Gunesin Family (collectively, “Polarchem”)
upon terms and conditions reasonably satisfactory to Osler which (i) supersedes in its entirety the General Agreement and Contract
between Polarchem and AGT Canada, and (ii) vests in AGT all rights to the exclusive distribution of Polarchem products as previously
granted to AGT Canada.

 

                              (g)            Participation
of AGT Shareholders in Share Exchange. The holders of 100% of the outstanding shares of AGT Common Stock shall participate
in the Transaction.

 

               7.2.         Conditions
Precedent to the Obligation of AGT and the AGT Shareholders to Close. The obligations of each of AGT and the AGT Shareholders
to effect the Transaction and consummate the other transactions contemplated hereby are subject to the fulfillment or satisfaction,
prior to or on the Closing Date, of the following conditions; provided that these conditions are for AGT’s
and the AGT Shareholders’ sole benefit and may be waived only by either AGT or the AGT Shareholders, as applicable, at any
time in their sole discretion by providing Osler with prior written notice thereof:

 

                              (a)            Representations,
Warranties, Covenants and Agreements. The representations and warranties of Osler and Smith herein shall be true and correct
as of the date when made and as of the Closing Date as though made at that time (except for representations and warranties that
speak as of a specific date, which shall be true and correct as of such date), and Osler shall have performed, satisfied and complied
with the covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by them at
or prior to the Closing Date. AGT shall have received a certificate, executed by Smith on Osler’s behalf, dated as of the
Closing Date, to the foregoing effect and as to such other matters as may be reasonably requested by AGT.

 

                              (b)            Osler
Resolutions. The Osler Board of Directors shall have adopted, and not rescinded or otherwise amended or modified, resolutions
authorizing Osler’s entry into this Agreement and the consummation of the transactions contemplated hereby and thereby,
including the Transaction and the issuance of the Exchange Shares.

 

                              (c)            No
Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted,
entered, promulgated or endorsed by any court or governmental authority of competent jurisdiction which prohibits the consummation
of any of the transactions contemplated by this Agreement.

    	13

    	 

    

                              (d)            No
Material Adverse Changes; Timely Filings. There shall have been no adverse effect on the business, operations,
properties, prospects or financial condition of Osler that is material and adverse to Osler taken as a whole.
Osler shall have timely filed its required filings with the SEC, which shall comply in form and substance to the rules
and regulations of the SEC, shall be current in its reporting obligations and the Osler Common Stock shall be quoted on the OTCQB
Tier of the OTC Markets. 

 

                              (e)            Books
and Records. AGT shall have been provided full access to Osler’s auditors pursuant to the provisions of Section
6.2 hereof. Osler shall have delivered all accounting books and records, accounting files including the general ledger and QuickBooks
or similar electronic files and supporting documents through the Closing Date, together with all other books and records, including
its corporate minute book, all access codes, EDGAR filing codes, passwords and other information necessary to access such information,
together with such additional documents as are deemed necessary by AGT to transfer control of Osler to it.

 

                              (f)             Financial
Statements. The AGT Financial Statements shall be suitable for filing with the SEC as part of the “Super
8-K” to be filed by Osler following the Closing pursuant to the rules and regulations of the SEC.

 

                              (g)            Satisfaction
of Liabilities. Osler shall deliver to AGT evidence satisfactory to AGT in its sole discretion that all Osler Liabilities,
including accounts payable, accrued expenses and loan payable which totaled $13,136 at December 31, 2013 pursuant to the Osler
SEC Documents, together with any and all subsequent obligations of Osler from December 31, 2013 through the Closing Date, whether
accrued or not, have been satisfied in full or otherwise forgiven, it being the intention of the parties hereto that (i) at the
Closing Osler shall have no liabilities of any nature whatsoever, whether accrued or not, at the Closing Date, including, but
not limited to, legal and accounting fees, EDGAR filing fees, transfer agent fees or any other fees or expenses whatsoever, and
(ii) AGT shall be responsible for the payment of any liabilities of Osler which are incurred following the Closing Date, including
the legal and accounting fees associated with the “Super 8-K.”

 

                              (h)            Schedule
14F-1. The Schedule 14F-1 disclosing the change in majority directors of Osler shall have been on file with the SEC at
least 10 days prior to the Closing Date.

 

                              (i)             Participation
of AGT Shareholders in Exchange. The holders of 100% of the outstanding AGT Common Stock shall participate in the Transaction.

 

                              (j)             Resignations.
On the Closing Date, Smith shall have resigned and immediately prior to such resignation shall have appointed Messrs. Michael
C. Boyko, Ricardo A. Barbosa and James Mack the new officers and directors of Osler.

 

                              (l)             Miscellaneous.
Osler and Smith shall have delivered to AGT such other documents relating to the transactions contemplated by this Agreement
as AGT may reasonably request.

 

SECTION 8

SURVIVAL OF
REPRESENTATIONS AND WARRANTIES OF OSLER AND SMITH

 

               Notwithstanding
any right of AGT and the AGT Shareholders to fully to investigate the affairs of Osler, AGT and the AGT Shareholders shall have
the right to rely fully upon the representations, warranties, covenants and agreements of Osler and Smith contained in this Agreement
or in any document delivered to AGT and/or the AGT Shareholders by Osler or any of its representatives, in connection with the
transactions contemplated by this Agreement. All such representations, warranties, covenants and agreements shall survive the
execution and delivery hereof and the Closing Date hereunder for 12 months following the Closing.

    	14

    	 

    

SECTION 9

SURVIVAL OF
REPRESENTATIONS AND WARRANTIES OF AGT AND THE AGT SHAREHOLDERS

 

               Notwithstanding
any right of Osler and Smith fully to investigate the affairs of AGT, Osler and Smith has the right to rely fully upon the representations,
warranties, covenants and agreements of AGT and the AGT Shareholders contained in this Agreement or in any document delivered
to Osler by the AGT and/or the AGT Shareholders or any of its or their representatives, in connection with the transactions contemplated
by this Agreement. All such representations, warranties, covenants and agreements shall survive the execution and delivery hereof
and the Closing Date hereunder for 12 months following the Closing.

 

SECTION 10

TERMINATION
AND AMENDMENT

 

               10.1        Termination.
This Agreement may be terminated prior to the Closing as follows:

 

                              (a)             Termination
by Mutual Consent. This Agreement may be terminated at any time prior to the Closing by mutual written consent of the
parties hereto.

 

                              (b)             Termination
by Either AGT or Osler. This Agreement may be terminated by either AGT or Osler at any time prior to the Closing as follows:

 

                                               (i)            if
the Closing has not occurred by March 31, 2014 (the “Outside Date”), except that the right to terminate
this Agreement under this clause will not be available to any party whose failure to fulfill any of its obligations under this
Agreement has been a principal cause of, or resulted in, the failure to consummate the Closing by such date; or

 

                                               (ii)           if
any law or governmental authority prohibits consummation of the Closing or if any order, judgment, injunction, award, decree or
writ handed down, adopted or imposed by, any court of competent jurisdiction or governmental authority restrains, enjoins or otherwise
prohibits consummation of the Closing, and such order, judgment, injunction, award, decree or writ has become final and nonappealable.

 

                              (c)             Termination
by AGT. This Agreement may be terminated by AGT at any time prior to the Closing if a breach or failure of any representation,
warranty or covenant of Osler or Smith contained in this Agreement shall have occurred, which breach (A) would reasonably be expected
to give rise to the failure of a condition set forth in Section 7.2; and (B) as a result of such breach, such condition would
not be capable of being satisfied prior to the Outside Date; provided that AGT is not in material breach of its
obligations under this Agreement. 

 

                              (d)             Termination
by Osler. This Agreement may be terminated by Osler at any time prior to the Closing, if a breach or failure of any representation,
warranty or covenant of AGT contained in this Agreement shall have occurred, which breach (A) would reasonably be expected to
give rise to the failure of a condition set forth in Section 7.1 and (B) as a result of such breach, such condition would not
be capable of being satisfied prior to the Outside Date; provided that Osler is not in material breach of its obligations
under this Agreement.

    	15

    	 

    

                              (e)            Effect
of Termination. If this Agreement is terminated pursuant to this Section 10, it will become void and of no further force
and effect, with no liability on the part of any party (or any of their respective former, current, or future general or limited
partners, shareholders, stockholders, managers, members, directors, officers, affiliates or agents), except that the provisions
of this Section 10 will survive any termination of this Agreement; provided, however, that nothing herein shall
relieve any party (or any of their respective directors or officers) from liabilities for damages incurred or suffered by another
party as a result of any fraud perpetrated, conspired in or otherwise committed by such party (or any of their respective directors
or officers) or any knowing or intentional breach by a party of any of its representations, warranties, covenants or other agreements
set forth in this Agreement that caused, or would reasonably be expected to cause, any of the conditions set forth in Sections
7.1 or 7.2, as applicable, not to be satisfied.

 

               10.2        Amendment
of Agreement. This Agreement may be amended by the parties at any time prior to the Closing; provided, that
(a) no amendment that requires stockholder approval under applicable laws, rules and regulations will be made without such required
further approval and (b) such amendment has been duly authorized or approved by the parties. This Agreement may not be amended,
modified or supplemented except by an instrument in writing signed by AGT, the AGT Shareholders, Osler and Smith. Any such amendment
shall apply to, and bind all parties.

 

SECTION 11

INDEMNIFICATION

 

               11.1        Obligation
of Osler and Smith to Indemnify. Subject to the limitations on the survival of representations and warranties contained
in Section 9, each of Osler and Smith hereby agree to jointly and severally indemnify, defend and hold harmless AGT and each of
the AGT Shareholders from and against any losses, liabilities, damages, deficiencies, costs or expenses (including interest, penalties
and reasonable attorneys’ fees and disbursements) (a “Loss”) based upon, arising out of, or otherwise
due to any inaccuracy in or any breach of any representation, warranty, covenant or agreement of Osler or Smith contained in this
Agreement or in any document or other writing delivered pursuant to this Agreement.

 

               11.2        Obligation
of AGT to Indemnify. Subject to the limitations on the survival of representations and warranties contained in Section
9, AGT agrees to indemnify, defend and hold harmless Osler, Smith and the AGT Shareholders to the extent provided for herein from
and against any Loss based upon, arising out of, or otherwise due to any inaccuracy in or any breach of any representation, warranty,
covenant or agreement made by any of them and contained in this Agreement or in any document or other writing delivered pursuant
to this Agreement.

 

               11.3        Obligation
of the AGT Shareholders to Indemnify. Subject to the limitations on the survival of representations and warranties contained
in Section 9, each of the AGT Shareholders severally agrees to indemnify, defend and hold harmless Osler, Smith, AGT and the remaining
AGT Shareholders to the extent provided for herein from and against any Loss based upon, arising out of, or otherwise due to any
inaccuracy in or any breach of any representation, warranty, covenant or agreement made by any of them and contained in this Agreement
or in any document or other writing delivered pursuant to this Agreement.

    	16

    	 

    

SECTION 12

POST CLOSING
OBLIGATIONS

 

               12.1        PAN
Consulting Shares. AGT is a party to that certain Consulting Agreement dated December 20, 2013 (the “Consulting
Agreement”) with PAN Consultants Ltd. (“PAN”) pursuant to which, as additional compensation
to PAN under the terms of the Consulting Agreement, it has agreed that should AGT consummate a merger, acquisition, or other form
of business combination with a publicly-held shell company during the term of the agreement, as additional compensation PAN shall
be entitled to purchase, subsequent to the Closing, such number of shares of Osler Common Stock as shall equal the greater of
1,500,000 shares or 7.88% of the issued and outstanding shares at a purchase price which is the lesser of par value or $0.001
per share. The parties hereto acknowledge that following the Closing, prior to the filing of the “Super 8-K”, AGT
shall cause Osler to issue a 1,500,000 shares of Osler Common Stock to PAN (the “PAN Consulting Shares”)
for nominal consideration under the terms of the Consulting Agreement.

 

               12.2        IMS
Registration Rights. During the one (1) year period following the filing of the “Super 8-K” by Osler with
respect to the Closing of the Transaction, in the event Rule 144 under the Securities Act should not be available for IMS for
the resale of all or any portion of the Control Shares by it, upon thirty days (30) written notice by IMS to Osler (the “Demand
Notice”), IMS shall be entitled to demand that Osler file a registration statement
on Form S-1 (the “Resale Registration Statement”) with the Securities and Exchange Commission (the “Commission”)
to register the Control Shares for resale. Osler shall use its reasonable best efforts to cause such Resale Registration Statement
to be filed with the Commission as soon as practicable following its receipt of the Demand Notice. Osler shall pay all fees and
expenses associated with the Resale Registration Statement, except for any legal or accounting fees of IMS and any brokerage commissions
or other costs incurred by it upon the resale of the Control Shares. Osler shall use its reasonably best efforts to cause the
Commission to declare the Resale Registration Statement effective as soon as possible.

 

SECTION 13

MISCELLANEOUS

 

               13.1        Waivers.
The waiver of a breach of this Agreement or the failure of any party hereto to exercise any right under this agreement shall in
no event constitute waiver as to any future breach whether similar or dissimilar in nature or as to the exercise of any further
right under this Agreement.

 

               13.2        Amendment.
This Agreement may be amended or modified only by an instrument of equal formality signed by the parties or the duly authorized
representatives of the respective parties.

 

               13.3        Binding
Agreement; Assignment. This Agreement shall be binding upon the parties hereto and their respective heirs, legal representatives,
successors and permitted assigns. This Agreement is not assignable except by operation of law.

 

               13.4        Notices.
Until otherwise specified in writing, the mailing addresses of both parties of this Agreement shall be as follows:

 

	               If to AGT:	 	254
    South Mulberry Street
	 	 	 	Suite 113
	 	 	 	Meza, AZ 85202
	 	 	 	 
	               With a copy to:	 	36-5531 Cornwall
    Drive
	 	 	 	Richmond, BC CanadaV7C
    5N7
	 	 	 	Attention: Mr.
    John P. Mooney

    	17

    	 

    

	               If
    to an AGT Shareholder:	 	to the address
    set forth on AGT Shareholder’s
	 	 	 	signature page
    hereto
	 	 	 	 
	               If
    to Osler and Smith:	 	900 SE Third Avenue
	 	 	 	Suite 202
	 	 	 	Fort Lauderdale, FL 33316

 

Any notice or
statement given under this Agreement shall be deemed to have been given if sent by certified mail, return receipt requested, overnight
courier or personal delivery, to the other party(ies) at the addresses indicated above or at such other address or number as may
be furnished in writing in accordance with this paragraph.

 

               13.5        Governing
Law; Venue. This Agreement shall be governed and construed in accordance with the laws of the State of Nevada, without
regard to the conflicts of law provisions thereof. Each party hereby irrevocably submits to the exclusive jurisdiction of the
state and federal courts sitting in the County of Broward County, State of Florida, for the adjudication of any dispute hereunder
or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and
agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any
such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or
proceeding is improper. Each party hereby irrevocably waives personal service of process and consents to process being served
in any such suit, action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this
agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained
herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. If any provision of this
agreement shall be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability shall not affect the validity
or enforceability of the remainder of this agreement in that jurisdiction or the validity or enforceability of any provision of
this agreement in any other jurisdiction. EACH PARTY HERETO IRREVOCABLY WAIVES ANY RIGHT TO TRIAL BY JURY.

 

               13.6        Publicity.
No publicity release or announcement concerning this Agreement or the transactions contemplated hereby shall be issued by either
party hereto at any time from the signing hereof without advance approval in writing of the form and substance thereof by the
other party.

 

               13.7        Entire
Agreement. This Agreement (including the Exhibits and Schedules hereto) and the collateral agreements executed in connection
with the consummation of the transactions contemplated herein contain the entire agreement among the parties with respect to the
Transaction and issuance of the Exchange Shares and related transactions, and supersede all prior agreements, written or oral,
with respect thereto.

 

               13.8        Headings.
The headings in this Agreement are for reference purposes only and shall not in any way affect the meaning or interpretation of
this Agreement.

 

               13.9        Severability
of Provisions. The invalidity or unenforceability of any term, phrase, clause, paragraph, restriction, covenant, agreement
or other provision of this Agreement shall in no way affect the validity or enforcement of any other provision or any part thereof.

 

               13.10      Counterparts;
Facsimile. This Agreement may be executed in any number of counterparts, each of which, when so executed, shall constitute
an original copy hereof, but all of which together shall consider but one and the same document. This Agreement may be executed
and delivered by facsimile transmission or pdf via email and when so executed and delivered shall have the same effect as if the
receiving party had received an original counterpart of this Agreement.

    	18

    	 

    

               IN
WITNESS WHEREOF, the parties have executed this Agreement on the date first above written.

 

	 	OSLER
    INCORPORATED
	 	 	 
	 	By: 	 
	 	 	C. Leo Smith,
    President
	 	 	 
	 	AMERICA GREENER TECHNOLOGIES CORPORATION
	 	 	 
	 	By:	
	 	 	Michael C. Boyko,
    President

 

[SIGNATURE
PAGES FOR AGT SHAREHOLDERS TO FOLLOW]

    	19

    	 

    

AGT
SHAREHOLDER SIGNATURE PAGE FOR ENTITY SHAREHOLDER

 

(the
information must conform exactly to the certificate(s)

representing
the shares of AGT Common Stock)

	 	 	 	 	 
	Type of ownership
    (check one):	o	corporation
	 	o	partnership
	 	o	limited
    liability company
	 	o	limited
    liability partnership
	 	o	trust
	 	o	other
    (specify) 	 
	 	 	 
	 	 	 
	 	 	Name
    of Entity (Print)
	 	 	 
	 	 	By: 	 
	 	 	Signature
    of Purchaser’s Authorized Signatory
	 	 	 
	 	 	
	 	 	Name
    of Purchaser’s Authorized Signatory
	 	 	(Print)
	 	 	 
	 	 	Principal
    Business or Mailing Address
	 	 	 
	 	 	
	 	 	City,
    State and Zip Code
	 	 	 
	 	 	Taxpayer
    Identification No.
	 	 	 
	 	 	Name of Natural Person who
    has Voting and Dispositive Control over the shares of AGT Common Stock

    	20

    	 

    

AGT
SHAREHOLDER SIGNATURE PAGE FOR INDIVIDUAL SHAREHOLDER, OR IF THE AGT SHARES ARE HELD AS JOINT TENANTS, AS TENANTS IN COMMON, OR
AS COMMUNITY PROPERTY BY MORE THAN ONE INDIVIDUAL

 

(the
information must conform exactly to the certificate(s)

representing
the shares of AGT Common Stock)

 

               IN
WITNESS WHEREOF, the parties have executed this Agreement on the date first above written. 

	 	 	 	 	 	 
	 	 	(Signature of AGT Shareholder)	 
	 	 	 	 	 	 
	 	 	(Name Typed or Printed)	 
	 	 	 	 	 	 
	 	 	(Signature of Co-AGT Shareholder)	 
	 	 	 	 	 	 
	 	 	(Name Typed or Printed)	 
	 	 	 	 	 	 
	Mailing Address	 	Residence Address	 
	(if not residence)	 	 	 	 
	 	 	 	 	 	 
	 	 	City, State and Zip Code	 
	City, State and
    Zip Code	 	 	 	 
	 	 	 	 	 
	 	 	Citizenship:	o	U.S.
	Social Security
    Number of AGT Shareholder(s)	 	(check one)	o	Non-U.S.
	 	 	 	 	Country 	 

	21Exhibit 10.1

 

SETTLEMENT AGREEMENT AND GENERAL
RELEASE

This Settlement Agreement, General Release,
Waiver of Rights, and Covenant Not to Sue (“this Agreement”) is entered into the day and year last set forth (the “Settlement
Date”), by and between Gemini Master Fund, Ltd. (together with any successors and assigns, collectively, “Gemini”)
and Aethlon Medical, Inc. (“Aethlon”). Each signatory to this Agreement is referred to herein as a “Party”
and, collectively, as the “Parties.”

 

A.          Gemini received certain warrants from
Aethlon in each of 2008, 2009 and 2010 (respectively, the “2008 Warrant,” the “2009 Warrant” and the “2010
Warrant”; collectively, the “Warrants”) as well as a convertible Note that matured in 2012 (the “Convertible
Note”).

 

B.          The following litigation is pending between
the Parties: Gemini Master Fund, Ltd. v. Aethlon Medical, Inc., Index No. 652358/2012, in the Supreme Court of New York,
New York County (the “Litigation”).

 

C.          The Parties have agreed to settle and
compromise any and all claims that each has made, or could have made in the Litigation. The Parties are entering into this Agreement
to avoid the uncertainty and expense of further litigation and to compromise and settle the claims asserted in the Litigation.

 

NOW, THEREFORE, in consideration of the foregoing,
and the mutual covenants and conditions hereinafter set forth, the parties hereto agree as follows:

 

1.          Consideration to Gemini.

 

(a)         Cash. Within fourteen business days of the execution of this Agreement, Aethlon’s insurance carrier
shall issue a check in the amount of one hundred fifty thousand dollars ($150,000) payable to Gemini Master Fund, Ltd. and counsel
for Aethlon will send the check to Gemini Master Fund, Ltd., c/o Gemini Strategies, 619 South Vulcan Ave., Suite #203, Encinitas,
CA 92024.

 

(b)         Simultaneous with the execution of this Agreement, Gemini shall execute the three Notices of Exercise of the Warrants
in the form attached as exhibits B-1, B-2 and B-3. Simultaneous with the execution of this Agreement, Aethlon shall fulfill
the Notices of Exercise by instructing Aethlon’s transfer agent to issue and deliver to the Escrow Agent twenty certificates
– 19 certificates in the amount of 376,143 shares each and the 20th certificate totaling 376,137 shares –
which in the aggregate total 7,522,854 shares which is equal to the total number of shares requested on the three Notices of Exercise.
The 7,522,854 shares to be issued to fulfill the Notices of Exercise are known in this Agreement as the “Warrant Shares.”
The Warrant Shares shall be in the name of Knotfloat & Co. f/b/o Gemini Master Fund, Ltd. and shall be without restrictive
legend. The Parties agree that the number of shares to be issued under each Warrant is equal to or less than the number Gemini
claims in the litigation or otherwise to be entitled to receive, however Aethlon acknowledges and agrees that Gemini has the right
to receive the Warrant Shares under the Warrants upon delivery of the Exercise Notices. Effective upon delivery of the Warrant
Shares to the Escrow Agent, the Warrants, Convertible Note and any other right to receive securities previously issued or granted
by Aethlon to Gemini are hereby canceled and shall have no further force and effect and Gemini shall have no right or entitlement
to any further shares from Aethlon other than as described in this Agreement. Gemini agrees to return the original Warrants marked
“terminated” to Aethlon within five business days following the delivery of the certificates to the Escrow Agent or
alternatively, to provide an affidavit that it has made a diligent search and been unable to locate the original Warrants. If the
original Warrants cannot be located, Gemini will indemnify and hold Aethlon harmless for any costs (including reasonable attorneys’
fees), claim, injury, damage, harm, cause of action, or other act related to or arising out of anyone’s attempt to exercise
any one or more of the Warrants or Aethlon’s refusal to fulfill any notice of exercise related to any one or more of the
Warrants (other than the requirement for Aethlon to fulfill the three Notices of Warrants attached to this Agreement as required
by and described in this Agreement).

 

    	1

    	 

    

 

2.          Consideration
to Aethlon. Within two (2) business days of the delivery of the Warrant Share certificates to the Escrow Agent and delivery
of the other Consideration set forth in paragraph 1, Gemini shall deliver a Stipulation of Discontinuance in the form attached
as Exhibit C which provides that all claims in the Litigation are dismissed with prejudice. Each Party shall bear
its own costs, expenses and attorneys’ fees incurred in the Litigation, including any fees and costs associated with the
preparation of this Agreement.

 

3.          The
Delivery of the Warrant Shares to Gemini.

 

(a)         Gemini and Aethlon appoint Olshan Frome Wolosky LLP to act as Escrow Agent for the Warrant Shares in accordance with
the terms of the Escrow Agreement annexed as Exhibit D.

 

(b)         Pursuant to the Escrow Agreement, on the first and fifteenth day of each month, the Escrow Agent shall release one
of the share certificates to Gemini, until all certificates have been delivered. If the release date is a Saturday, Sunday or holiday,
the Escrow Agent may release the shares the preceding business day.

 

(c)         For so long as the Escrow Agent holds any certificates, Gemini shall not engage in any short sales of Aethlon common
stock within the meaning of SEC Regulation SHO. In the event that Gemini engages in short sales in breach of this covenant, Aethlon
shall be entitled to recover as liquidated damages 200% of any profits received as a result of any breach.

 

4.          Aethlon’s
Representations and Acknowledgments. Aethlon represents and warrants that:

 

(a)         All Warrant Shares have been duly authorized and upon issuance will be fully-paid and non-assessable.

 

(b)         Upon
issuance, and based upon the accuracy of Gemini’s representations and warranties in the Selling Shareholder letter in the
form attached as Exhibit E, the Warrant Shares shall be freely transferable without restriction under Rule 144 of the Securities
Act of 1933, as amended (the “Securities Act”) (except for the limitations set forth in this Agreement).

 

(c)         This Settlement has been duly approved by Aethlon’s Board and is a valid and binding agreement.

 

5.          Gemini’s Representations and Covenants. Gemini represents and warrants that:

 

(a)         Gemini does not now beneficially or of record own shares of Aethlon stock or have the right to acquire shares of
Aethlon stock, except for its rights under the Warrants at issue in the Litigation.

 

(b)         Gemini has not assigned or transferred any of its rights under the Warrants or to the claims stated in the Litigation.

 

(c)         Gemini acknowledges and agrees that the shares delivered pursuant to paragraph b are on account of the following
Warrant exercises:

 

2008 Warrant – 402,159;

2009 Warrant – 402,159;

2010 Warrant – 6,728,536;

 

(d)         This Settlement has been duly approved by Gemini’s Board and is a valid and binding agreement.

 

    	2

    	 

    

 

6.          Mutual
Releases.

 

(a)         Release by Aethlon. In exchange for the consideration provided by Gemini and the other covenants contained
herein, Aethlon does hereby and for its attorneys, insurers, agents, servants, employees, officers, directors, parent companies,
subsidiaries, successors and assigns release, acquit and forever discharge Gemini and its attorneys, insurers, agents, servants,
employees, officers, directors, parent companies, subsidiaries, successors and assigns of and from any and all claims, actions,
causes of action, demands, rights, claims for damages, costs, expenses and compensation whatsoever, whether known or unknown, which
it may now have against Gemini arising out of or in any way relating to the Litigation, the Warrants, or the Convertible Note,
excepting only those claims arising from this Agreement.

 

(b)         Release by Gemini. In exchange for the consideration provided by Aethlon and the other covenants contained
herein, Gemini does hereby and for its attorneys, insurers, agents, servants, employees, officers, directors, parent companies,
subsidiaries, successors and assigns release, acquit and forever discharge Aethlon and its attorneys, insurers, agents, servants,
employees, officers, directors, parent companies, subsidiaries, successors and assigns of and from any and all claims, actions,
causes of action, demands, rights, claims for damages, costs, expenses and compensation whatsoever, whether known or unknown, which
it may now have against Aethlon arising out of or in any way relating to the Litigation, the Warrants, or the Convertible Note
excepting only those claims arising from this Agreement.

 

7.          General
Release. The releases set forth in the preceding paragraphs are general releases in connection with the claims, demands, causes
of action, obligations, damages or liabilities which are the subject of this Agreement and are intended to encompass all known
and unknown, foreseen and unforeseen claims which each Party hereto may have against the other, excepting only claims arising
from this Agreement. It is further understood and agreed that all rights under Section 1542 of the Civil Code of the State
of California and any similar law of any state or territory of the United States are hereby expressly waived by each Party hereto.
Section 1542 provides as follows:

 

“SECTION 1542. CERTAIN CLAIMS ARE NOT AFFECTED
BY GENERAL RELEASE. A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS, WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR
HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT
WITH THE DEBTOR.”

8.          Right
to Execute Agreement. Each Party hereto hereby warrants that no other person has or had, or claims any interest in any of
the claims, counterclaims, demands, causes of action, obligations, damages or liabilities asserted by it referred to herein; that
it has the sole right and exclusive authority to execute this Agreement and to bind itself and its successors and assigns hereby;
that it has not sold, assigned, transferred, conveyed or otherwise disposed of any claim, demand, cause of action, obligation,
damage or liability asserted by it referred to herein. Each person signing this Agreement on behalf of a partnership, corporation
or other legal entity warrants and represents that he has full authority to bind such partnership, corporation or entity to the
full terms and conditions of this Agreement and all other documents executed by him hereunder.

 

9.          Agreement
Not An Admission. No provision of this Agreement shall be construed in any event as an admission of any liability of any kind
by any Party hereto to any other Party.

 

10.         No
Representations Not Contained Herein. Each Party acknowledges that no other Party, nor any agent or attorney of any Party,
has made any promise, representation or warranty whatsoever, express or implied, not expressly contained herein, concerning the
subject matter hereto so as to induce it to execute this Agreement and each Party acknowledges that it has not executed this Agreement
in reliance on any promise, representation or warranty not contained herein.

 

    	3

    	 

    

 

11.         Waiver
and Modification. No provision of this Agreement may be waived unless such waiver is in writing, signed by all of the Parties.
Waiver of any one provision herein shall not be deemed a waiver of any other provision herein. This Agreement may be modified
or amended only by a written agreement signed by all of the Parties.

 

12.         Representation
by Counsel. Each Party represents that it is and has been represented by counsel of its own choice in the Litigation and in
connection with this Agreement, and has received independent legal advice from its attorneys with respect to the negotiation and
advisability of entering into this Agreement, the settlement and release for which this Agreement provides, and the execution
of this Agreement.

 

13.         No
Representations. Each Party acknowledges and represents that, in executing this Agreement, such Party has not relied on any
inducements, promises, or representations made by any Party or any party representing or serving such Party, unless expressly
set forth in a written agreement.

 

14.         Disputed Claim. This Agreement pertains to a disputed claim and does not constitute an admission of liability
or wrongdoing by any Party for any purpose.

 

15.         Covenant
Regarding Assignment. The Parties each represent and warrant that it is the sole and lawful owner of all right, title and
interest in and to every claim and other matter which each purports to release herein, and that it has not heretofore assigned
or transferred, or purported to assign or transfer, to any person, firm, association, corporation or other entity, any right,
title or interest in any such claim or other matter. In the event that such representation is false, and any such claim or matter
is asserted against any party hereto (and/or the successor of such party) by any party or entity who is the assignee or transferee
of such claim or matter, the Party shall fully indemnify, defend and hold harmless the party against who such claim or matter
is asserted (and its successors) from and against such claim or matter and from all actual costs, demands, fees, expenses, liabilities,
and damages which that party (and/or its successors) incurs as a result of the assertion of such claim or matter. It is the intention
of the Parties that this indemnity does not require payment as a condition precedent to recovery by a party under this indemnity.

 

16.         Modifications.
This Agreement may not be amended, canceled, revoked or otherwise modified except by written agreement subscribed by all of the
parties to be charged with such modification.

 

17.         Attorneys’
Fees. Each Party shall pay its own costs and attorneys’ fees except as follows:

 

(a)         In the event of any action, suit or other proceeding instituted to remedy, prevent or obtain relief from a breach
of this Agreement, arising out of a breach of this Agreement, involving claims within the scope of the releases contained in this
Agreement, or pertaining to a declaration of rights under this Agreement, the prevailing party shall recover all of such party’s
attorneys’ fees and costs incurred in each and every such action, suit or other proceeding, including any and all appeals
or petitions therefrom.

 

(b)         As used herein, attorneys’ fees shall be deemed to mean the full and actual costs of any legal services actually
performed in connection with the matters involved, calculated on the basis of the usual fee charged by the attorneys performing
such services.

 

18.         Notices.
All notices shall be sent by overnight courier and by e-mail to the addresses designated below and shall be deemed received on
the date of transmission.

 

    	4

    	 

    

 

	If to Aethlon:	James Joyce

Aethlon Medical, Inc.

8910 University Center Lane

San Diego, CA 92122

jjoyce@aethlonmedical.com
	 	 
	with a copy to:	Mark A. Robertson

Fulbright & Jaworski LLP

666 Fifth Avenue

New York, NY 10103

(212) 318-3304

mark.robertson@nortonrosefulbright.com
	 	 
	If to Gemini:	Steven Winters

Managing Partner

Gemini Master Fund, LLC

619 South Vulcan, Suite 203

Encinitas, CA 92024

steve@geministrategies.com
	 	 
	with a copy to:	Thomas J. Fleming

Olshan Frome Wolosky LLP

Park Avenue Tower

65 East 55th Street

New York, NY 10022

(212) 451-2300

tfleming@olshanlaw.com
	 	 

19.         Forum.
The Parties each (1) consent to the exclusive jurisdiction of the federal or state courts located in New York County, New York
in connection with any dispute relating to this Agreement, (2) will accept service of process by overnight courier in any such
suit, (3) waive any defense based upon an inconvenient forum, and (4) waive any right to a trial by jury.

 

20.         Counterparts.
This Agreement may be executed by the parties in counterparts, each of which is an original, but all of which together shall constitute
one executed original.

 

21.         Inapplicability
of California Civil Code section 1654. Each Party acknowledges that it participated in the drafting of this Agreement
and agrees that any uncertainty herein is the fault of both of the Parties and, therefore, California Civil Code section 1654
or any comparable statute is not applicable to the Agreement’s interpretation.

 

    	5

    	 

    

 

22.         Entire
Agreement. This Agreement constitutes the entire agreement between the Parties pertaining to the subject matter hereof and
supersedes all prior and contemporaneous agreements, understandings, negotiations, and discussions, whether oral or written, of
the Parties.

 

23.         Binding
Effect. This Agreement shall be binding upon and inure to the benefit of the Parties hereto and all successors, assigns, parent
companies and subsidiaries.

 

	 	AETHLON MEDICAL, INC.
	 	 
	Dated:  February  24, 2014	By:	
        /s/ James Joyce

	 	 	James Joyce
	 	Its:	Chief Executive Officer

 

 

	 	GEMINI MASTER FUND, LTD.
	 	 
	Dated:  February  24, 2014	By:	
        /s/ Steven Winters

	 	 	Steven Winters
	 	Its:	Managing Partner

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	6

    	 

    

 

Exhibit A

No Exhibit A exists.

 

 

 

 

 

 

 

 

 

 

 

 

 

    	7

    	 

    

Exhibit B

 

FORM OF SUBSCRIPTION

(to be signed only on exercise of Warrant)

 

TO: AETHLON MEDICAL, INC.

The undersigned, pursuant to the provisions
set forth in the attached Warrant (No. 2008-C-001), hereby irrevocably elects to purchase (check applicable box):

 

___     _______ shares of the Common Stock
covered by such Warrant; or.

 

X         the maximum number of shares of
Common Stock covered by such Warrant pursuant to the cashless exercise procedure set forth in Section 2.

 

The undersigned herewith makes payment of the
full purchase price for such shares at the price per share provided for in such Warrant, which is $___________. Such payment takes
the form of $__________ in lawful money of the United States.

 

X        the
cancellation of such number of shares of Common Stock as is necessary, in accordance with the formula set forth in Section 2,
to exercise this Warrant with respect to the maximum number of shares of Common Stock purchasable pursuant to the cashless exercise
procedure set forth in Section 2.

 

Such cashless exercise is to be based upon
the following inputs:

 

Number of shares purchasable under this Warrant
= 660,000

Fair Market Value = $0.17918

Purchase Price = $0.07

 

Therefore, the cashless exercise formula is
660,000 x (($0.17918-$0.07)/$0.17918 = 402,159 shares to be issued under this Warrant and 257,841 shares are to be cancelled.

 

The undersigned requests that the certificates
for such shares be issued in the name of, and delivered to _____________________________________________________ whose address
is ______________________________________________

 

The undersigned represents and warrants that
all offers and sales by the undersigned of the securities issuable upon exercise of the within Warrant shall be made pursuant to
registration of the Common Stock under the Securities Act of 1933, as amended (the "Securities Act"), or pursuant to
an exemption from registration under the Securities Act.

 

	Dated:___________________	
        _________________________

        (Signature must conform to name of holder as specified on the face
        of the Warrant)

         

        _________________________

        _________________________

        (Address)

 

 

    	8

    	 

    

 

Exhibit B (continued)

 

FORM OF SUBSCRIPTION

(to be signed only on exercise of Warrant)

 

TO: AETHLON MEDICAL, INC.

The undersigned, pursuant to the provisions
set forth in the attached Warrant (No. 2009-07-10-001), hereby irrevocably elects to purchase (check applicable box):

 

___     _______ shares of the Common Stock
covered by such Warrant; or.

 

X        the
maximum number of shares of Common Stock covered by such Warrant pursuant to the cashless exercise procedure set forth in Section
2.

 

The undersigned herewith makes payment of the
full purchase price for such shares at the price per share provided for in such Warrant, which is $___________. Such payment takes
the form of $__________ in lawful money of the United States.

 

X        the
cancellation of such number of shares of Common Stock as is necessary, in accordance with the formula set forth in Section 2,
to exercise this Warrant with respect to the maximum number of shares of Common Stock purchasable pursuant to the cashless exercise
procedure set forth in Section 2.

 

Such cashless exercise is to be based upon
the following inputs:

 

Number of shares purchasable under this Warrant
= 660,000

Fair Market Value = $0.17918

Purchase Price = $0.07

 

Therefore, the cashless exercise formula is
660,000 x (($0.17918-$0.07)/$0.17918 = 402,159 shares to be issued under this Warrant and 257,841 shares are to be cancelled.

 

The undersigned requests that the certificates
for such shares be issued in the name of, and delivered to _____________________________________________________ whose address
is ______________________________________________

 

The undersigned represents and warrants that
all offers and sales by the undersigned of the securities issuable upon exercise of the within Warrant shall be made pursuant to
registration of the Common Stock under the Securities Act of 1933, as amended (the "Securities Act"), or pursuant to
an exemption from registration under the Securities Act.

 

	Dated:___________________	
        _________________________

        (Signature must conform to name of holder as specified on the face
        of the Warrant)

         

        _________________________

        _________________________

        (Address)

 

 

    	9

    	 

    

 

Exhibit B (continued)

 

NOTICE OF EXERCISE OF WARRANT

	TO:	AETHLON MEDICAL, INC.
	 	ATTN: Jim Frank
		VIA FAX TO: (858) 272-2738

 

The
undersigned hereby irrevocably elects to exercise the right, represented by the Warrant to Purchase Shares of Common Stock dated
as of November 22, 2010 (the “Warrant”), to purchase shares of the Common Stock, $0.001 par value
(“Common Stock”), of AETHLON MEDICAL, INC. , and tenders herewith payment in accordance with
Section 2 of the Warrant, as follows:

 

	______	CASH:
$_________________________________= (Exercise Price x number of shares of Common Stock issuable
upon exercise (“Exercise Shares”)
	 	 
	______	Payment is being made by:
	 	 
	 	______ enclosed check
	 	______ wire transfer
	 	______ other
	 	 
	___X__	CASHLESS EXERCISE:
	 	 
	 	Net number of Warrant Shares to be issued to Holder: 6,728,536*
	 	 
	 	* based on:     Current Market Value - (Exercise
Price x Exercise Shares)
	 	Adjusted Price of Common Stock
	 	 
	 	Where:	
	 	Market Price of Common Stock [“MP”]	= $0.245
	 	Current Market Value [MP x Exercise Shares]	= $1,234,800
	 	Exercise Price	= $0.18379001
	 	Adjusted Price of Common Stock	= $0.18379001
	 	 

Capitalized
terms used but not otherwise defined herein shall have the meanings ascribed to them in the Warrant.

It is
the intention of the Holder to comply with the provisions of Section 2.2 of the Warrant regarding certain limits on the Holder's
right to exercise thereunder. The Holder believes this exercise complies with the provisions of such Section 2.2. Nonetheless,
to the extent that, pursuant to the exercise effected hereby, the Holder would have more shares than permitted under Section 2.2,
this notice should be amended and revised, ab initio, to refer to the exercise which would result in the issuance of the
maximum number of shares permitted under such provision. Any exercise above such amount is hereby deemed void and revoked.

    	1

    	 

    

As
contemplated by the Warrant, this Notice of Exercise is being sent by facsimile/email to the fax
number/email address and officer indicated above.

If this Notice of Exercise represents the full exercise of the outstanding balance
of the Warrant, the Holder either (1) has previously surrendered the Warrant to the Company or (2) will surrender (or cause to
be surrendered) the Warrant to the Company at the address indicated above by express courier within five (5) Trading Days after
delivery or email or facsimile transmission of this Notice of Exercise.

 

The certificates
representing the Warrant Shares should be transmitted by the Company to the Holder

 

_______
via express courier, or

_______ by electronic transfer

 

after receipt of this Notice of Exercise (by
facsimile transmission or otherwise) to:

 

_________________________________

_________________________________

_________________________________

 

Dated: _____________________________

 

 

___________________________________

[Name
of Holder]

 

By:________________________________

 

    	10

    	 

    

 

 

Exhibit C

SUPREME COURT OF THE STATE OF NEW YORK

COUNTY OF NEW YORK

	
         

        GEMINI MASTER FUND, LTD.,

         

        Plaintiff,

         

        -against-

         

        AETHLON MEDICAL, INC.,

         

        Defendant.

         
	
         

        Index No. 652358/2012

         

        STIPULATION OF DISMISSAL OF ACTION WITH PREJUDICE

         

         

 

IT IS HEREBY STIPULATED AND AGREED, by
and among the parties to the above-captioned action by their undersigned attorneys of record, that pursuant to CPLR § 3217(a)(2),
this action is hereby voluntarily discontinued with prejudice with each party to bear its own costs, no party hereto is an infant,
incompetent person for whom a committee has been appointed or conservatee and no person not a party has an interest in the subject
matter of the action.

 

	Dated: February __, 2014	 	Dated: February __, 2014
	 	 	 
	FULBRIGHT & JAWORSKI LLP	 	OLSHAN FROME WOLOSKY LLP
	 	 	 
	By:	
 

	 	By:	
 

	 	Mark A. Robertson

666 Fifth Avenue

New York, NY 10103

(212) 318-3304

mark.robertson@nortonrosefulbright.com	 	 	Thomas J. Fleming (TF4423)

Park Avenue Tower

65 East 55th Street

New York, New York 10022

(212) 451-2300
	 	 	 	 	 
	Attorneys for Defendant	 	Attorneys for Plaintiff

 

 

 

 

 

 

    	11

    	 

    

 

Exhibit D

ESCROW AGREEMENT

THIS ESCROW AGREEMENT (this “Agreement”),
dated as of February __, 2014, is made by and among by and among Aethlon Medical, Inc., a Nevada corporation (“Aethlon”),
Gemini Master Fund Ltd. (“Gemini”) and Olshan Frome Wolosky LLP, a New York limited liability partnership, as escrow
agent (the “Escrow Agent”).

WHEREAS, Aethlon and Gemini have entered
into a Settlement Agreement dated of even date herewith (the “Settlement Agreement”) which, among other things,
provides for the delivery by Aethlon of the Warrant Shares, as that term is defined in the Agreement, to the Escrow Agent; and

WHEREAS, the parties have requested that
the Escrow Agent hold the Escrow Property in accordance with the terms hereof.

NOW, THEREFORE, in consideration of the
covenants and mutual promises contained herein and other good and valuable consideration, the receipt and legal sufficiency of
which are hereby acknowledged, and intending to be legally bound hereby, the parties agree as follows:

24.         Appointment
of Escrow Agent; Establishment of Escrow.

 

(a)          The parties hereto hereby designate and appoint Olshan Frome Wolosky LLP as the Escrow Agent for the purposes set
forth herein, and the Escrow Agent hereby accepts such appointment on the terms herein provided.

 

(b)          The
“Escrow Property” shall consist of twenty certificates for shares of Aethlon Common Stock in the amounts set forth
in the Settlement Agreement and any proceeds derived from any Escrow Property held by the Escrow Agent, including shares received
in any stock split or as a dividend.

 

(c)          Aethlon has delivered the Escrow Property to the Escrow Agent upon execution hereof. The Escrow Property shall be
held, administered and disposed of by the Escrow Agent in accordance with the terms and conditions hereinafter set forth.

 

25.         Release
of the Escrow Property.

 

(a)          Upon satisfaction of each Escrow Release Condition (as defined below), Escrow Agent shall deliver to Gemini a single
Certificate for Aethlon Common Stock, accompanied by a release notice in the form attached hereto as Exhibit A (a “Release
Notice”).

 

(b)          An Escrow Release Condition shall occur on the first and fifteenth day of each month after the date of this Agreement,
until all certificates have been delivered. If the release date is a Saturday, Sunday or holiday, the Escrow Agent may release
the shares the preceding business day. In the event that Aethlon announces an agreement to sell, merge, or engage in any other
transaction involving a change of control, the Escrow Agent shall release to Gemini all remaining shares that it holds.

 

(c)          Following the delivery of all of the Escrow Property to Gemini in accordance with the terms hereof, the Escrow Agent
will have no further obligation or liability under this Agreement.

 

    	12

    	 

    

 

26.         Miscellaneous.

 

(a)          To
induce the Escrow Agent to act hereunder, it is further agreed by the other parties hereto that:

 

The Escrow Agent shall not be under any
duty to give the Escrow Property held by it hereunder any greater degree of care than it gives its own similar property and shall
not be required to invest any funds held hereunder. Funds held hereunder shall not earn or accrue interest.

This Escrow Agreement expressly sets forth
all the duties of the Escrow Agent with respect to any and all matters pertinent hereto. No implied duties or obligations shall
be read into this Escrow Agreement against the Escrow Agent. The Escrow Agent shall not be bound by the provisions of any agreement
among the other parties hereto except this Escrow Agreement.

The Escrow Agent shall not be liable for
any action taken or omitted hereunder, except for its own gross negligence or willful misconduct and, except with respect to claims
based upon such gross negligence or willful misconduct that are successfully asserted against the Escrow Agent, the other parties
hereto shall jointly and severally indemnify and hold harmless the Escrow Agent (and any successor Escrow Agent) from and against
any and all losses, liabilities, claims, actions, damages and expenses, including reasonable attorneys’ fees and disbursements,
arising out of and in connection with this Escrow Agreement.

The Escrow Agent shall be entitled to rely
upon any order, judgment, certification, demand, notice, instrument or other writing delivered to it hereunder without being required
to determine the authenticity or the correctness of any fact stated therein or the propriety or validity or the service thereof.
The Escrow Agent may act in reliance upon any instrument or signature reasonably believed by it to be genuine and may assume that
any person purporting to give receipt or advice or make any statement or execute any document in connection with the provisions
hereof has been duly authorized to do so.

The Escrow Agent may act pursuant to the
advice of counsel with respect to any matter relating to this Escrow Agreement and shall not be liable for any action taken or
omitted in accordance with such advice.

The Escrow Agent does not have any interest
in the Escrow Property deposited hereunder but is serving as escrow holder only and having only possession thereof.

The Escrow Agent makes no representation
as to the validity, value, genuineness or the collectability of any security or other document or instrument held by or delivered
to it.

The Escrow Agent shall not be called upon
to advise any party as to the wisdom in selling or retaining or taking or refraining from any action with respect to any securities
or other property deposited hereunder.

The Escrow Agent (and any successor Escrow
Agent) may at any time resign such position by delivering the Escrow Property to any successor Escrow Agent jointly designated
by the other parties hereto in writing, or to any court of competent jurisdiction, whereupon the Escrow Agent shall be discharged
of and from any and all further obligations arising in connection with this Escrow Agreement. The resignation of the Escrow Agent
will take effect on the earlier of (a) the appointment of a successor (including a court of competent jurisdiction) or (b) the
day that is 30 days after the date of delivery of its written notice of resignation to the other parties hereto. If the Escrow
Agent has not received a designation of a successor Escrow Agent, the Escrow Agent’s sole responsibility after that time
shall be to safekeep the Escrow Property until receipt of a designation of successor Escrow Agent or a joint written disposition
instruction by the other parties hereto or a final, non-appealable order of a court of competent jurisdiction.

    	13

    	 

    

In the event (i) of any disagreement between
the other parties hereto resulting in adverse claims or demands being made in connection with the Escrow Property, or (ii) the
Escrow Agent in good faith is in doubt as to what action it should take hereunder, the Escrow Agent shall be entitled to retain
the Escrow Property until the Escrow Agent shall have received (A) a final, non-appealable order of a court of competent jurisdiction
directing delivery of the Escrow Property or (B) a written agreement executed by the other parties hereto directing delivery of
the Escrow Property, in which event the Escrow Agent shall disburse the Escrow Property in accordance with such order or agreement.
Any court order shall be accompanied by a legal opinion by counsel for the presenting party satisfactory to the Escrow Agent to
the effect that said opinion is final and non-appealable. The Escrow Agent shall act on such court order and legal opinions without
further question. Notwithstanding the foregoing, if requested by Aethlon, in the event of a dispute or disagreement between Aethlon
and Gemini with respect to the Escrow Property disbursement that is not resolved within a reasonable time, the Escrow Agent shall
deposit the Escrow Property with a court of competent jurisdiction and interplead the other parties hereto in accordance with applicable
rules of legal procedure.

The other parties hereto hereby irrevocably
submit to the jurisdiction of any New York state or federal court sitting in the State of New York, County of New York in any action
or proceeding arising out of or relating to this Escrow Agreement, and the parties hereby irrevocably agree that all claims in
respect of such action or proceeding arising out of or relating to this Escrow Agreement shall be heard and determined in such
a New York state or federal court. The other parties hereby consent to and grant to any such courts exclusive jurisdiction over
the persons of such parties, and waive any claims of forum non conveniens, and over the subject matter of any such dispute and
agree that delivery or mailing of any process or other papers in the manner provided herein above, or in such other manner as may
be permitted by law, shall be valid and sufficient service thereof. In any suit arising under this Escrow Agreement, the parties
hereby consent to service of process by mail as proper and waive any and all defenses related to service of process otherwise available
under law.

No printed or other matter in any language
(including without limitation prospectuses, notices, reports and promotional material) that mentions the Escrow Agent’s name
or the rights, powers, or duties of the Escrow Agent shall be issued by the other parties hereto or on such parties’ behalf
unless the Escrow Agent shall first have given its specific written consent thereto.

This Escrow Agreement shall be binding
upon and inure solely to the benefit of the parties hereto and their respective successors and assigns, heirs, administrators and
representatives and shall not be enforceable by or inure to the benefit of any third party except as provided in paragraph (i)
with respect to a resignation by the Escrow Agent. No party may assign any of its rights or obligations under this Escrow Agreement
without the written consent of the other parties.

This Escrow Agreement shall be construed
in accordance with and governed by the internal laws of the State of New York (without reference to its rule as to conflicts of
law to the extent that the general application of the laws of another jurisdiction would be required thereby).

(b)          No waiver or any breach of any covenant or provision herein contained shall be deemed a waiver of any preceding or
succeeding breach thereof, or of any other covenant or provision herein contained. No extension of time for performance of any
obligation or act shall be deemed an extension of the time for performance of any other obligation or act.

 

(c)          This Escrow Agreement is the final expression of, and contains the entire agreement between, the parties with respect
to the subject matter hereof and supersedes all prior understandings with respect thereto. This Escrow Agreement may not be modified,
changed, supplemented or terminated, nor may any obligations hereunder be waived, except by written instrument signed by the parties
to be charged or by its agent duly authorized in writing or as otherwise expressly permitted herein.

 

(d)          Whenever required by the context of this Escrow Agreement, the singular shall include the plural and masculine shall
include the feminine. This Escrow Agreement shall not be construed as if it had been prepared by one of the parties, but rather
as if both parties had prepared the same.

 

    	14

    	 

    

 

(e)          The
Escrow Agent shall be obligated only for the performance of such duties as are specifically set forth herein and may rely and
shall be protected in relying or refraining from acting on any instrument reasonably believed by the Escrow Agent to be genuine
and to have been signed or presented by the proper party or parties. The Escrow Agent shall not be personally liable for any act
the Escrow Agent may do or omit to do hereunder as the Escrow Agent while acting in good faith and in the absence of gross negligence
or willful misconduct, and any act done or omitted by the Escrow Agent pursuant to the advice of the Escrow Agent’s attorneys-at-law
shall be conclusive evidence of such good faith, in the absence of gross negligence or willful misconduct.

 

(f)          The Escrow Agent is hereby expressly authorized to disregard any and all warnings given by any of the parties hereto
or by any other person or corporation, excepting only orders or process of courts of law and is hereby expressly authorized to
comply with and obey orders, judgments or decrees of any court. In case the Escrow Agent obeys or complies with any such order,
judgment or decree, the Escrow Agent shall not be liable to any of the parties hereto or to any other person, firm or corporation
by reason of such decree being subsequently reversed, modified, annulled, set aside, vacated or found to have been entered without
jurisdiction.

 

(g)          The
Escrow Agent shall not be liable in any respect on account of the identity, authorization or rights of the parties executing or
delivering or purporting to execute or deliver a Subscription Agreement or any documents or papers deposited or called for thereunder
in the absence of gross negligence, fraud and willful misconduct.

 

(h)          The Escrow Agent shall be entitled to employ such legal counsel and other experts as the Escrow Agent may deem necessary
properly to advise the Escrow Agent in connection with the Escrow Agent’s duties hereunder, may rely upon the advice of such
counsel, and may pay such counsel reasonable compensation therefor which shall be paid by the Escrow Agreement unless otherwise
provided therefore elsewhere in this Agreement. The Escrow Agent has acted as legal counsel for and may continue to act as legal
counsel for Gemini from time to time, notwithstanding its duties as the Escrow Agent hereunder. Aethlon consents to the Escrow
Agent also serving as legal counsel for Gemini and waives any claim that such representation represents a conflict of interest
on the part of the Escrow Agent. Gemini and Aethlon understand that the Escrow Agent is relying explicitly on the foregoing provision
in entering into this Escrow Agreement.

 

(i)          If the Escrow Agent reasonably requires other or further instruments in connection with this Escrow Agreement or
obligations in respect hereto, the necessary parties hereto shall join in furnishing such instruments.

 

(j)          Aethlon and Gemini agree jointly and severally to indemnify and hold harmless the Escrow Agent and its partners,
employees, agents and representatives from any and all claims, liabilities, costs or expenses in any way arising from or relating
to the duties or performance of the Escrow Agent hereunder or the transactions contemplated hereby or by the Subscription Agreements
other than any such claim, liability, cost or expense to the extent the same shall have been determined by final, unappealable
judgment of a court of competent jurisdiction to have resulted from the gross negligence, fraud or willful misconduct of the Escrow
Agent.

 

27.         Notices.
Any notice, request, demand or other communication permitted or required to be given hereunder shall be in writing, shall be sent
by one of the following means to the addressee at the address set forth below (or at such other address as shall be designated
hereunder by notice to the other parties and persons receiving copies, effective upon actual receipt) and shall be deemed conclusively
to have been given: (a) upon hand delivery or upon delivery by telecopy, or facsimile at the address or number designated below
(if delivered on a business day during normal business hours where such notice is to be received), or the first business day following
such delivery (if delivered other than on a business day during normal business hours where such notice is to be received), (b)
on the business day following the date of mailing by overnight courier service, fully prepaid, addressed to such address, or (c)
upon actual receipt of such mailing, whichever shall first occur.

 

    	15

    	 

    

 

	If to Aethlon:	James Joyce

Aethlon Medical, Inc.

8910 University Center Lane

San Diego, CA 92122

jjoyce@aethlonmedical.com
	 	 
	with a copy to:	Mark A. Robertson

Fulbright & Jaworski LLP

666 Fifth Avenue

New York, NY 10103

(212) 318-3304

mark.robertson@nortonrosefulbright.com
	 	 
	If to Gemini:	Steven Winters

Managing Partner

Gemini Master Fund, LLC

619 South Vulcan, Suite 203

Encinitas, CA 92024

steve@geministrategies.com
	 	 
	with a copy to:	Thomas J. Fleming

Olshan Frome Wolosky LLP

Park Avenue Tower

65 East 55th Street

New York, NY 10022

(212) 451-2300

tfleming@olshanlaw.com
	 	 

 

[SIGNATURE PAGE FOLLOWS]

    	16

    	 

    

IN WITNESS WHEREOF, the parties have
executed this Escrow Agreement as of the date set forth above.

	 	AETHLON MEDICAL, INC.
	 	 
	 	By:	

	 	 	 
	 	Its:	 

 

 

	 	GEMINI MASTER FUND, LTD.
	 	 
	Dated:  February __, 2014	By:	

	 	 	Steven Winters
	 	Its:	Managing Partner

 

 

	Agreed and Accepted as of the date first written above:
	 
	OLSHAN FROME WOLOSKY LLP,

as Escrow Agent
	 
	 
	By:	

	 	Name:	Thomas J. Fleming
	 	Title:	Partner

 

 

 

    	17

    	 

    

 

EXHIBIT A

Gemini Master Fund

Aethlon Medical, Inc.

Release Notice

[DATE]

Dear Sirs:

This letter serves to inform you that
an Escrow Release Condition (as defined and set forth in the Escrow Agreement, dated as of February __, 2014 (the “Escrow
Agreement”), by and among Aethlon Medical, Inc., Gemini Master Fund Ltd. and Olshan Frome Wolosky LLP, as escrow agent,
has occurred, and that a certificate for _________ shares (“Released Escrow Property”) of Common Stock of Aethlon Medical,
Inc. has been delivered to Gemini Master Fund Ltd. or its designee.

 

 

 

 

 

 

 

    	18

    	 

    

Exhibit E

Seller’s Representation Letter for

Legend Removal from Restricted Securities

Pursuant to Rule 144(b)(1)

(Non-Affiliate – One-Year Holding Period)

 

Please complete this form with respect to the
sale of restricted securities if you have held your shares for more than one year and are not an “affiliate” of the
issuer of the shares.

 

Name of Seller: ________________________________________________

 

I am requesting removal of the restrictive
legends from _______________ shares (the “Shares”) of Common Stock of Aethlon Medical, Inc. (the “Company”)
through _________________ (the “Broker”) in accordance with Rule 144 (“Rule 144”) promulgated under the
Securities Act of 1933, as amended (the “Securities Act”), in connection with a proposed sale of the Shares. In connection
with such sale, I represent and warrant that:

		1.	The Shares are “restricted securities,” as that term is defined in Rule 144(a)(3),
and I acquired and fully paid for the Shares on _____________ (date of issuance of the Warrant being exercised) in the following
manner:

 

		a.       	Method of acquisition: ______________________________________

 

		b.       	Manner of payment for Warrant and Warrant Shares:  ______________________________________

		2.	I am not now, nor have I been during the preceding three months, a(n) officer, director or more
than 10% shareholder of the Company or, in any other way, an “affiliate” of the Company (as that term is defined in
Rule 144(a)(1)).

		3.	I have been the beneficial owner of the Shares for a period of at least one year, as computed in
accordance with Rule 144(d).

		4.	The Company is not a shell company as described in Rule 144(i)(1), and if formerly a shell company,
at least one year has elapsed from the time the Company filed Form 10 information with the Securities and Exchange Commission reflecting
the fact that it had ceased to be a shell company.

		5.	This transaction is not part of a plan or scheme to evade the registration requirements of the
Securities Act.

		6.	I have provided you with all stock certificates (or Warrants) that I have representing the Shares.

		7.	I do not possess any material, nonpublic information regarding the Company or its prospects, and,
if at any time before the sale of the Shares is completed or an order for such sale is rescinded, I obtain any such information,
I will immediately rescind my order for such sale.

 

I acknowledge that the Company and its counsel
may rely upon the completeness and accuracy of the statements contained herein. I agree to indemnify and hold the Company and its
counsel harmless from and against all losses, costs, liabilities and expenses that may arise out of my sale of the Shares in violation
of the Securities Act or any other applicable rules or regulations.

 

Signatures:

Note: The signature(s) must correspond with
the name(s) written on the face of the certificate(s) or Warrants in every particular without alteration.

 

	 	 	 	 	 
	Signature: Seller	 	Print name as it appears on certificate	 	Date
	 	 	 	 	 
	Signature: Additional Seller	 	Print name as it appears on certificate	 	Date

 

    	19

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00227-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00227-of-00352.parquet"}]]